Salinity is one of the most pervasive threats to global agriculture. As sodium chloride accumulates in soil and irrigation water, it disrupts nearly every aspect of plant physiology. Excess sodium ions interfere with the uptake of potassium, an essential nutrient, collapsing the delicate K⁺/Na⁺ balance that cells depend on for enzyme function and membrane potential. Salt stress also triggers the overproduction of reactive oxygen species such as hydrogen peroxide, which attack lipids in cell membranes, a process measured as lipid peroxidation and reflected in elevated levels of malondialdehyde. The result is electrolyte leakage, wilting, chlorophyll degradation, and ultimately reduced yield and quality. With soils degrading worldwide, researchers are urgently searching for cheap, safe compounds that can prime crops to withstand these conditions, and dopamine has emerged as one of the most promising candidates.

The Iranian team designed a factorial experiment that subjected fenugreek plants to three levels of salinity, 0, 150, and 300 millimolar sodium chloride, combined with four exogenous dopamine treatments at 0, 100, 200, and 400 micromolar. They then measured a comprehensive battery of physiological, biochemical, hormonal, and molecular responses, tracking everything from chlorophyll content and relative water content to the expression of genes along the diosgenin biosynthetic pathway. This integrated approach allowed them to connect the dots between what dopamine does at the whole-plant level and what it does at the level of individual genes, a linkage that is often missing from studies of stress-protective chemicals.

The damage inflicted by severe salinity alone was substantial. Under 300 millimolar sodium chloride, total chlorophyll fell by 54 percent and relative water content dropped by 59 percent, while the K⁺/Na⁺ ratio sank to 0.86, signaling a serious breakdown of ion homeostasis. At the same time, the plants showed the classic fingerprints of oxidative stress: lipid peroxidation rose, electrolyte leakage increased, and hydrogen peroxide accumulated. The stress hormone abscisic acid surged, as did nitric oxide and the plant’s own endogenous dopamine, suggesting that fenugreek recognizes salt stress and attempts to mobilize its internal signaling reserves, but that this endogenous response is insufficient on its own to prevent significant injury.

Exogenous dopamine changed that picture dramatically, and the 200 micromolar dose proved to be the sweet spot. In salt-stressed plants receiving this treatment, total chlorophyll climbed from 8.59 to 15.60 milligrams per gram of fresh weight, an increase of 80 percent, while relative water content rose from 51.6 to 65.6 percent, a 28 percent improvement. The K⁺/Na⁺ ratio, the single most important indicator of how well a plant excludes sodium while retaining potassium, jumped from 0.38 to 0.94, a striking 147 percent increase. This restoration of ionic balance suggests that dopamine either strengthens the mechanisms that pump sodium out of the cytosol or improves the selectivity of membrane transporters, allowing the plant to keep functioning biochemically even in a salty root zone.

The protective effects extended deep into the oxidative and hormonal spheres. Malondialdehyde, the standard marker of membrane damage, fell by 34 percent, from 17.33 to 11.4 micromoles per gram of fresh weight, while electrolyte leakage dropped by 26 percent and hydrogen peroxide by 40 percent. In other words, dopamine substantially limited the oxidative destruction that salt stress normally inflicts on cell membranes. Meanwhile, the treatment boosted signaling molecules that help plants coordinate their stress responses: nitric oxide rose by 40 percent, abscisic acid by 51 percent, and auxin by 84 percent, the latter climbing from 13.96 to 25.82 nanograms per gram of fresh weight. Endogenous dopamine itself also accumulated, increasing by 60 percent in shoots and 107 percent in roots, indicating that exogenous application primes the plant’s own dopaminergic machinery rather than simply acting as a passive antioxidant.

Perhaps the most intriguing part of the study concerns diosgenin, the steroidal sapogenin that makes fenugreek commercially and medicinally valuable. Diosgenin serves as a precursor in the industrial synthesis of steroid drugs, including corticosteroids and contraceptive hormones, and demand for plant-derived supplies remains strong. The researchers found that dopamine’s effects on the diosgenin biosynthetic genes were salinity-dependent in a fascinating way. At moderate salinity of 150 millimolar sodium chloride combined with 200 micromolar dopamine, the genes BGL and C4 reached their peak expression, at 19.05-fold and 8.84-fold induction respectively. Under severe salinity of 300 millimolar with the same dopamine dose, a different set of genes took center stage: C26, CAS, SEP, SMT, SQS, and SSR were maximally induced at 17.83-, 18.00-, 13.66-, 11.33-, 10.66-, and 28.00-fold respectively. This layered transcriptional response shows that dopamine does not simply switch the pathway on or off; it fine-tunes different enzymatic steps depending on how much stress the plant is experiencing.

These gene-expression changes translated into real chemical output. Fenugreek plants treated with 200 micromolar dopamine under salt stress accumulated the highest diosgenin content recorded in the study, 103.33 milligrams per gram of fresh weight, representing a 390 percent increase over untreated control plants and a 209 percent increase over plants exposed to salinity alone. The magnitude of this enhancement is notable because stress and secondary metabolism are often linked: plants frequently produce more defensive compounds when challenged, but severe stress usually degrades overall plant health to the point where total metabolite yield falls. Dopamine appears to break this trade-off, allowing the plant to mount a full defensive chemistry program while simultaneously preserving the photosynthetic capacity, water status, and ion balance needed to sustain it.

The authors conclude that exogenous dopamine at 200 micromolar alleviates salinity damage and promotes diosgenin biosynthesis through coordinated regulation of water status, ion homeostasis, hormonal and oxidative balance, and key biosynthetic genes. The practical implications are twofold. For farmers in salt-affected regions, dopamine-based treatments could offer a low-cost way to keep fenugreek productive on marginal land, complementing breeding programs and soil remediation efforts. For the pharmaceutical and nutraceutical industries, the same treatment could turn fenugreek into a more reliable and potent source of diosgenin, potentially reducing reliance on other botanical sources such as Dioscorea yams. The researchers emphasize that their findings support future field validation and mechanistic studies, and indeed, greenhouse results with foliar or root-applied elicitors do not always translate directly to open-field conditions, where application methods, soil chemistry, and weather all modulate outcomes.

Still, the study adds to a growing body of evidence that dopamine deserves a central place in the plant stress-signaling toolkit. Its dual action, protecting membranes and photosystems while simultaneously rewiring metabolic gene expression, makes it a uniquely versatile elicitor, and the salinity-dependent gene regulation observed here hints at a sophisticated crosstalk between stress perception and specialized metabolism that warrants deeper investigation. As salinity continues to encroach on arable land and as demand for plant-derived steroidal compounds keeps rising, the idea that a single, inexpensive molecule could address both problems at once is exactly the kind of win-win that sustainable agriculture needs. For fenugreek, an ancient crop with modern pharmaceutical relevance, dopamine may prove to be the key to thriving where salt would otherwise win.

Subject of Research: Dopamine-mediated salinity tolerance and diosgenin biosynthesis in fenugreek

Article Title: Dopamine enhances salinity tolerance and elicits diosgenin biosynthesis in fenugreek (Trigonella foenum-graecum L.)

Article References: Hosseinzadeh, M. A., Ebrahimi, A., & Gharanjik, S. (2026). Dopamine enhances salinity tolerance and elicits diosgenin biosynthesis in fenugreek (Trigonella foenum-graecum L.). BMC Plant Biology. https://doi.org/10.1186/s12870-026-10031-9

Image Credits: AI Generated

DOI: 10.1186/s12870-026-10031-9

Keywords: dopamine, fenugreek, salinity stress, diosgenin, plant hormones, ion homeostasis, antioxidant defense, secondary metabolism, abscisic acid, auxin, nitric oxide, BMC Plant Biology

The target of the study is a family of proteins that cancer cells exploit with devastating efficiency: the antiapoptotic Bcl-2 family. Apoptosis, or programmed cell death, is the body’s built-in quality control system, removing damaged, aged, or unwanted cells through two main routes, the mitochondrial intrinsic pathway and the extrinsic death receptor pathway. The intrinsic route is governed by the Bcl-2 protein family, which includes antiapoptotic members such as Bcl-2, Bcl-xL, Bcl-w, and Mcl-1, and proapoptotic players like Bax, Bak, and a suite of BH3-only proteins. When proapoptotic proteins oligomerize on the mitochondrial outer membrane, they trigger mitochondrial outer membrane permeabilization, releasing cytochrome c, assembling the apoptosome with Apaf-1, and activating the caspase enzymes that dismantle the cell. Antiapoptotic members act as guardians of the mitochondrial membrane, sequestering their proapoptotic relatives and preventing this point of no return.

Cancer cells frequently overexpress these antiapoptotic guardians, blocking the release of caspase-activating factors and thereby enhancing survival, proliferation, tumor progression, metastasis, angiogenesis, and drug resistance. This makes them attractive drug targets, particularly because they sit at the final, largely irreversible step of cell death, unlike upstream signaling pathways such as EGFR, PI3K, ALK, and BRAF, which tumors can bypass through compensatory mutations. Drugs like ABT-737, ABT-263, and venetoclax have demonstrated the therapeutic promise of this strategy, but resistance often emerges when other family members such as Mcl-1 or Bcl-xL are overexpressed. For this reason, the researchers selected obatoclax, a pan-Bcl-2 family inhibitor capable of targeting multiple antiapoptotic proteins simultaneously, as their reference compound rather than the more selective venetoclax.

The study, published in Results in Chemistry, cast a wide net across the plant kingdom. The team assembled a library of 698 bioactive phytocompounds drawn from eight medicinal plants with long histories of therapeutic use: Lycium barbarum, Asparagus racemosus, Curcuma longa, Acorus calamus, Moringa oleifera, Aristolochia indica, Taxus baccata, and Taxus brevifolia. These plants are rich sources of carotenoids, flavonols, polyphenols, flavonoids, sterols, alkaloids, and terpenoids, with documented antioxidant, antineoplastic, anti-inflammatory, and cytotoxic activities. Compound structures were retrieved from the NPASS, IMPPAT, and KNApSAcK databases, prepared with OpenBabel and Discovery Studio, and docked against crystal structures of Bcl-2, Bcl-xL, Bcl-w, and Mcl-1 obtained from the Protein Data Bank using AutoDock Vina within the PyRx platform.

The docking results were striking. Among the 698 compounds screened, only three, diosgenin, friedelin, and roridin E, outperformed obatoclax across all four antiapoptotic proteins, and diosgenin emerged as the clear leader. It achieved binding energies of −9.0 kcal/mol against Bcl-2, −9.3 kcal/mol against Bcl-xL, −8.5 kcal/mol against Bcl-w, and −8.2 kcal/mol against Mcl-1, consistently surpassing the control compound. Ligand efficiency analysis, which normalizes binding affinity by molecular size, confirmed that diosgenin offered a favorable balance between potency and molecular complexity, whereas larger compounds like violaxanthin achieved respectable scores only through sheer size. Receptor preference margin analysis further revealed that diosgenin favors multiple homologous Bcl-2 family proteins rather than a single receptor, with a preference order of Bcl-xL, followed by Bcl-2, Bcl-w, and Mcl-1, echoing the broad-spectrum profile that makes obatoclax clinically interesting.

Structural analysis showed why diosgenin binds so effectively. The compound occupies the hydrophobic groove formed by the BH1, BH2, and BH3 domains, the very pocket that antiapoptotic proteins use to grip the BH3 regions of their proapoptotic targets. With Bcl-2, diosgenin formed eight hydrophobic contacts involving residues such as Met-115, Val-156, Ala-149, Leu-137, Phe-104, and Phe-112. With Bcl-w, it generated thirteen hydrophobic interactions plus a hydrogen bond through Arg-95, engaging aromatic residues Phe-102 and Trp-137. Residue contact fingerprint analysis showed that phenylalanine, tyrosine, and leucine residues were conserved contact points across 75 percent of the target proteins, indicating that van der Waals and hydrophobic forces drive the interaction, and that diosgenin partially mimics the binding pattern of obatoclax while also forging unique contacts of its own. Redocking of co-crystallized ligands produced root-mean-square deviations below 2 angstroms for all targets, validating the docking protocol.

To confirm that these interactions would hold up in a dynamic, physiological environment, the team ran 200-nanosecond molecular dynamics simulations with the AMBER14 force field in YASARA under near-physiological conditions. The diosgenin-Bcl-xL complex proved more stable than the obatoclax control, with lower root-mean-square deviation, while the other complexes remained comparably stable. Root-mean-square fluctuation, solvent-accessible surface area, and radius of gyration analyses all pointed to compact, stable complexes, with diosgenin generally producing tighter protein conformations than the control. Hydrogen bond analysis revealed that diosgenin maintained roughly three hydrogen bonds with Bcl-2, more than double the control’s average, and secondary structure analysis confirmed that all proteins retained their predominantly alpha-helical folds throughout the simulations. MM-PBSA binding free energy calculations reinforced the picture, showing diosgenin complexes with Bcl-2 and Bcl-xL achieving more favorable energies than the control.

Perhaps most compelling are the drug-likeness and safety predictions. Diosgenin satisfied both Lipinski’s Rule of Five and Veber’s rules, showed high gastrointestinal absorption, crossed the blood-brain barrier, and, critically, did not inhibit any of the key cytochrome P450 enzymes, whereas obatoclax was predicted to interfere with CYP1A2, CYP3A4, and CYP2C19, raising the specter of drug-drug interactions. Toxicity profiling with ProTox-3 found diosgenin inactive for neurotoxicity, mutagenicity, hepatotoxicity, nephrotoxicity, carcinogenicity, and cardiotoxicity, with only mild predicted immunotoxicity, and a predicted median lethal dose of 8000 mg/kg compared with obatoclax’s 3066 mg/kg. Density functional theory calculations added a quantum mechanical dimension, showing a HOMO-LUMO energy gap of 5.279 eV for diosgenin versus 3.224 eV for obatoclax and a molecular electrostatic potential map indicating greater electron density and nucleophilicity for the plant compound.

These computational findings align intriguingly with a growing body of experimental literature. Previous studies have shown that diosgenin suppresses proliferation and triggers caspase-driven apoptosis in skin squamous carcinoma cells through AKT and JNK signaling, overcomes TRAIL resistance in colon cancer cells by downregulating the p38 MAPK pathway and elevating death receptor DR5, and curbs the invasion of triple-negative breast cancer cells by suppressing Vav2 phosphorylation and Cdc42 activation. In animal models, intra-tumoral diosgenin treatment markedly suppressed breast cancer xenograft growth in mice, and the compound reduced azoxymethane-induced aberrant crypt foci in rat models of colorectal cancer. The new study adds a mechanistic explanation for these observations: by wedging into the hydrophobic groove of antiapoptotic Bcl-2 family proteins, diosgenin could liberate proapoptotic effectors, drive mitochondrial outer membrane permeabilization, and push cancer cells irreversibly toward apoptosis.

The authors are careful to note the limits of their work. Every result, from the docking scores to the ADMET predictions, rests on computational models that require laboratory confirmation, and further in vitro and in vivo studies will be essential to establish diosgenin’s efficacy, bioavailability, and off-target profile in living systems. Still, the convergence of strong binding across all four antiapoptotic targets, stable simulated complexes, clean pharmacokinetics, and an exceptional predicted safety margin positions this humble plant saponin, found in fenugreek, wild yam, and other traditional remedies, as a genuinely promising scaffold for the next generation of Bcl-2 family inhibitors. If experimental validation keeps pace, a compound known to ancient healers may yet find a place in the modern oncology clinic.

Subject of Research: Computational identification of the natural plant compound diosgenin as an inhibitor of antiapoptotic Bcl-2 family proteins for cancer therapy

Article Title: Computational discovery of natural product-based anti-cancer agents targeting antiapoptotic family proteins through bioinformatics approach

Article References: Bulbul, M. I. A., Khan, T., Sharid, M. A. G., Shuvo, M. N., Debnath, A. C., Ali, M. A., & Haque, M. A. (2026). Computational discovery of natural product-based anti-cancer agents targeting antiapoptotic family proteins through bioinformatics approach. Results in Chemistry, 30, Article 103804. https://doi.org/10.1016/j.rechem.2026.103804

Image Credits: AI Generated

DOI: 10.1016/j.rechem.2026.103804

Keywords: diosgenin, Bcl-2 family proteins, apoptosis, molecular docking, molecular dynamics simulation, natural products, cancer drug discovery, MM-PBSA, ADMET prediction, obatoclax, phytocompounds, in silico drug design